They would definitely have two lots of results they could release that are overdue for both CHM CDH-17 and the Case Western AML trial.
Any positive news from these trials would have cemented confidence for shareholders and 708's looking to invest. As we saw yesterday, just how any good news impacts the share price. With further news it would have created a higher VWAP and lessen dilution.
I've been attempting to draw attention to the poor management practices but got no traction to drive change.
CHM Price at posting:
0.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)